和晶科技(300279.SZ)擬定增募資不超6.1億元 荊州慧康參與認購
格隆匯 8 月 24日丨和晶科技(300279.SZ)披露2020年度創業板向特定對象發行股票預案,此次向特定對象發行股票擬募集資金總額為不超過約6.1億元,扣除發行費用後用於以下項目:約4.27億元用於智能控制器擴產建設項目;約1.83億元用於償還銀行貸款及補充流動資金。
此次向特定對象發行股份總數不超過約1.35億股(不含此數),不超過此次發行前公司總股本的30%。
此次向特定對象發行股票的發行對象為包括公司控股股東荊州慧和的關聯方荊州慧康在內的不超過35名特定對象。其中荊州慧康認購不低於8000萬元且不超過1.2億元(含此數)。認購數量為實際認購金額除以實際認購價格(計算至個位數,結果向下取整)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.